23andMe Holding Co.

NasdaqCM:ME Stok Raporu

Piyasa değeri: US$126.9m

Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

23andMe Holding Yönetim

Yönetim kriter kontrolleri 1/4

Şu anda CEO hakkında yeterli bilgiye sahip değiliz.

Anahtar bilgiler

Anne Wojcicki

İcra Kurulu Başkanı

US$7.4m

Toplam tazminat

CEO maaş yüzdesi0.9%
CEO görev süresi18.8yrs
CEO sahipliği19.7%
Yönetim ortalama görev süresi2.1yrs
Yönetim Kurulu ortalama görev süresiVeri yok

Son yönetim güncellemeleri

Recent updates

Here's Why We're A Bit Worried About 23andMe Holding's (NASDAQ:ME) Cash Burn Situation

Apr 16
Here's Why We're A Bit Worried About 23andMe Holding's (NASDAQ:ME) Cash Burn Situation

Risks Still Elevated At These Prices As 23andMe Holding Co. (NASDAQ:ME) Shares Dive 26%

Mar 02
Risks Still Elevated At These Prices As 23andMe Holding Co. (NASDAQ:ME) Shares Dive 26%

We're Keeping An Eye On 23andMe Holding's (NASDAQ:ME) Cash Burn Rate

Jul 13
We're Keeping An Eye On 23andMe Holding's (NASDAQ:ME) Cash Burn Rate

23andMe Holding Co. (NASDAQ:ME) Investors Are Less Pessimistic Than Expected

Jun 15
23andMe Holding Co. (NASDAQ:ME) Investors Are Less Pessimistic Than Expected

23andMe: Disappointing Results Could Mean Potential Acquisition Target

Sep 27

23andMe: Treacherous Path To Profitability

Aug 26

23andMe drops 8% as CFO resigns

Aug 19

23andMe Holding Co. (NASDAQ:ME) Just Reported, And Analysts Assigned A US$5.00 Price Target

Aug 11
23andMe Holding Co. (NASDAQ:ME) Just Reported, And Analysts Assigned A US$5.00 Price Target

23andMe Q1 2023 Earnings Preview

Aug 07

23andMe: Holiday Miracles Not Enough, Growth Path Too Expensive

Jun 15

23andMe: A Genetics Innovator Positioned For Growth

Feb 19

Need To Know: Analysts Are Much More Bullish On 23andMe Holding Co. (NASDAQ:ME) Revenues

Feb 18
Need To Know: Analysts Are Much More Bullish On 23andMe Holding Co. (NASDAQ:ME) Revenues

23andMe: No Surprises With Recent Earnings, But Long-Term Story Remains Positive

Nov 21

23andMe Stock: Continued Drug-Development Progress Can Deliver Long-Term Gains

Oct 03

Companies Like 23andMe Holding (NASDAQ:ME) Are In A Position To Invest In Growth

Sep 17
Companies Like 23andMe Holding (NASDAQ:ME) Are In A Position To Invest In Growth

23andMe: New Therapeutic Pipeline And PGS Product Growth Catalyzed By +$696M In SPAC Funding

Jul 19

CEO Tazminat Analizi

Anne Wojcicki'un ücretlendirmesi 23andMe Holding'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Jun 30 2024n/an/a

-US$631m

Mar 31 2024US$7mUS$65k

-US$667m

Dec 31 2023n/an/a

-US$522m

Sep 30 2023n/an/a

-US$336m

Jun 30 2023n/an/a

-US$327m

Mar 31 2023US$63kUS$63k

-US$312m

Dec 31 2022n/an/a

-US$317m

Sep 30 2022n/an/a

-US$315m

Jun 30 2022n/an/a

-US$265m

Mar 31 2022US$33mUS$59k

-US$217m

Dec 31 2021n/an/a

-US$215m

Sep 30 2021n/an/a

-US$170m

Jun 30 2021n/an/a

-US$190m

Mar 31 2021US$20mUS$55k

-US$184m

Mar 31 2020US$51kUS$51k

-US$251m

Tazminat ve Piyasa: Anne 'nin toplam tazminatı ($USD 7.36M ), US pazarındaki benzer büyüklükteki şirketler için ortalamanın üzerindedir ($USD 665.80K ).

Tazminat ve Kazançlar: Anne şirketinin tazminatı, şirket kârsız olduğu sürece artırıldı.

CEO

Anne Wojcicki

18.8yrs

Görev süresi

US$7,363,723

Tazminat

Ms. Anne Wojcicki is the Co-Founder, CEO & Chair of 23andMe Inc. Ms. Anne had been a Director of Ajax I since October 30, 2020. Ms. Wojcicki serves as a General Partner of Covalence Life Sciences Partners....

Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Anne Wojcicki
Co-Founder18.8yrsUS$7.36m19.71%
$ 25.0m
Joseph Selsavage
Chief Financial & Accounting Officer2.1yrsUS$2.13m0.085%
$ 107.9k
Eli Fry
Vice President of Operationsless than a yearVeri yokVeri yok
Guy Chayoun
VP, Interim General Counsel & Corporate Secretaryless than a yearVeri yokVeri yok
Katie Watson
Vice President of Communicationsno dataVeri yokVeri yok
Jonathan Ward
Chief Marketing Officer2.8yrsVeri yokVeri yok
Savita Pillai
Vice President of People2.2yrsVeri yokVeri yok
Jennifer Low
Head of Therapeutics Development6.8yrsVeri yokVeri yok
Kent Hillyer
Vice President of Consumer Operationsno dataVeri yokVeri yok
Daniel Chu
Chief Product Officer2.1yrsVeri yokVeri yok
Tracy Keim
Chief Brand Officer1.3yrsVeri yokVeri yok
Frank Russo
Chief Security Officerless than a yearVeri yokVeri yok

2.1yrs

Ortalama Görev Süresi

55.5yo

Ortalama Yaş

Deneyimli Yönetim: ME 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 2.1 yıldır).